BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) CFO Anthony Doyle bought 36,300 shares of the stock in a transaction on Tuesday, May 14th. The stock was purchased at an average cost of $5.57 per share, for a total transaction of $202,191.00. Following the acquisition, the chief financial officer now owns 266,744 shares of the […]
BioCryst Pharmaceuticals (NASDAQ:BCRX) Price Target Raised to $15 00 at JMP Securities theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap Up to $5 69 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) shares reached a new 52-week low on Tuesday . The stock traded as low as $6.06 and last traded at $6.14, with a volume of 73957 shares. The stock had previously closed at $6.15. Wall Street Analysts Forecast Growth Several research firms have recently weighed in on […]
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) has been assigned a consensus rating of “Buy” from the seven brokerages that are currently covering the stock, Marketbeat reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokers that have issued ratings on the stock in […]